HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $390,625 | +94253.9% | 3,798 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $414 | -97.2% | 3,798 | -97.1% | 0.00% | -97.6% |
| Q4 2022 | $14,855 | -99.9% | 130,544 | -28.2% | 0.17% | +23.9% |
| Q3 2022 | $11,248,000 | +2.5% | 181,693 | +32.0% | 0.13% | +8.1% |
| Q2 2022 | $10,975,000 | -35.9% | 137,621 | -15.4% | 0.12% | -24.4% |
| Q1 2022 | $17,118,000 | +20.4% | 162,715 | +23.4% | 0.16% | +25.2% |
| Q4 2021 | $14,214,000 | -52.3% | 131,881 | -51.5% | 0.13% | -8.4% |
| Q3 2021 | $29,776,000 | +109.6% | 271,810 | +79.2% | 0.14% | +3.6% |
| Q2 2021 | $14,206,000 | +13.0% | 151,716 | +11.1% | 0.14% | +11.3% |
| Q1 2021 | $12,571,000 | +1.5% | 136,551 | -19.4% | 0.12% | -10.1% |
| Q4 2020 | $12,385,000 | -0.5% | 169,314 | +5.7% | 0.14% | -18.3% |
| Q3 2020 | $12,443,000 | +82.4% | 160,178 | +30.5% | 0.17% | +47.0% |
| Q2 2020 | $6,822,000 | +60.3% | 122,746 | -14.6% | 0.12% | +33.7% |
| Q1 2020 | $4,256,000 | -9.8% | 143,650 | +10.2% | 0.09% | +17.8% |
| Q4 2019 | $4,718,000 | +26.7% | 130,354 | -4.6% | 0.07% | +25.9% |
| Q3 2019 | $3,723,000 | -2.6% | 136,701 | -14.0% | 0.06% | 0.0% |
| Q2 2019 | $3,824,000 | -4.5% | 158,870 | +4.9% | 0.06% | -6.5% |
| Q1 2019 | $4,004,000 | – | 151,481 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |